ArticleCancer medicine2013

Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.

Anne-Sophie Chretien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.